There are truly some great people in society today. Unfortunately, the media doesn’t seem to report on the things that these extraordinary people partake in. The cancer research field just so happens to be home for one of the brightest of individuals in cancer research. This guy has a B.S. in Zoology from the University of Maryland, and the guy has a Ph.D in Genetics from George Washington University. He is also the founder of Seattle Genetics, which is a biotech organization that develops and commercializes advanced-cancer therapies. So who is this guy? The answer is quite simple.
Clay Siegall is his name and ridding the world of cancer is his game. This guy is the author of up to 70 health publications, and he is a well-accomplished professional that has a heart of gold. Dr. Clay Siegall, CEO of Seattle Genetics, has revolutionized this exclusive industry. He’s considered to be an old-guard of the scientific community, but his company specializes in some of the most advanced medications. This is a recipe for success because there are a lot of people who have benefited from the advanced medications. Siegall has always been very interested in medicine and the ability to restore people’s health. His father suffered from cancer when he was young, and he saw just how debilitating the disease could actually be. Amputation and radical surgery were the only options at that specific time, but Siegall knew that there could be a better way, which caused less suffering. This is where his divine intervention began, and he hasn’t looked back.
As of today, Seattle Genetics is one of the leaders in the field. The company has been around since the late 1990s, but it has consistently grown throughout the years. There are nearly 1,000 staff members at its Bothell, Washington, location. Antibody-drug conjugates are the name of the game, and they’re far more advanced at fighting cancer than their predecessors. With Dr. Clay Siegall on the scene, the future outlook of fighting this disease is much more brighter.